product summary
Loading...
company name :
R&D Systems
product type :
protein
product name :
Recombinant Mouse LIGHT/TNFSF14 Protein, CF
catalog :
1794-LT-025/CF
quantity :
25 ug
price :
432 USD
more info or order :
citations: 8
Reference
Liang Q, Xie J, Yu C, Feng Z, Ma J, Zhang Y, et al. Splenectomy improves liver fibrosis via tumor necrosis factor superfamily 14 (LIGHT) through the JNK/TGF-β1 signaling pathway. Exp Mol Med. 2021;53:393-406 pubmed publisher
Sibilano R, Gaudenzio N, DeGorter M, Reber L, Hernandez J, Starkl P, et al. A TNFRSF14-Fc?RI-mast cell pathway contributes to development of multiple features of asthma pathology in mice. Nat Commun. 2016;7:13696 pubmed publisher
Herro R, Antunes R, Aguilera A, Tamada K, Croft M. The Tumor Necrosis Factor Superfamily Molecule LIGHT Promotes Keratinocyte Activity and Skin Fibrosis. J Invest Dermatol. 2015;135:2109-2118 pubmed publisher
Freeman B, Hammarlund E, Raué H, Slifka M. Regulation of innate CD8+ T-cell activation mediated by cytokines. Proc Natl Acad Sci U S A. 2012;109:9971-6 pubmed publisher
Doherty T, Soroosh P, Khorram N, Fukuyama S, Rosenthal P, Cho J, et al. The tumor necrosis factor family member LIGHT is a target for asthmatic airway remodeling. Nat Med. 2011;17:596-603 pubmed publisher
Aebischer J, Cassina P, Otsmane B, Moumen A, Seilhean D, Meininger V, et al. IFN? triggers a LIGHT-dependent selective death of motoneurons contributing to the non-cell-autonomous effects of mutant SOD1. Cell Death Differ. 2011;18:754-68 pubmed publisher
Kayamuro H, Yoshioka Y, Abe Y, Katayama K, Yoshida T, Yamashita K, et al. TNF superfamily member, TL1A, is a potential mucosal vaccine adjuvant. Biochem Biophys Res Commun. 2009;384:296-300 pubmed publisher
Mueller A, Pedre X, Killian S, David M, Steinbrecher A. The Decoy Receptor 3 (DcR3, TNFRSF6B) suppresses Th17 immune responses and is abundant in human cerebrospinal fluid. J Neuroimmunol. 2009;209:57-64 pubmed publisher
product information
master code :
1794-LT/CF
SKU :
1794-LT-025/CF
product name :
Recombinant Mouse LIGHT/TNFSF14 Protein, CF
unit size :
25 ug
description :
The Recombinant Mouse LIGHT/TNFSF14 Protein, CF from R&D Systems is derived from NS0. The Recombinant Mouse LIGHT/TNFSF14 Protein, CF has been validated for the following applications: Bioactivity.
target :
LIGHT/TNFSF14
category :
Proteins and Enzymes
buffer :
Lyophilized from a 0.2 ╡m filtered solution in PBS.
conjugate :
Unconjugated
purity :
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining.
species :
Mouse
observed molecular weight :
24-34 kDa, reducing conditions
theoretical molecular weight :
21 kDa
gene symbol :
Tnfsf14
details of functionality :
Measured in a cytotoxicity assay using HT-29 human colon adenocarcinoma cells Yu,áK.Y. etáal . (1999) J.áBiol. Chem. 274 :13733; Harrop,áJ.A. etáal . (1998) J.áBiol. Chem. 273 :27548; Zhai,áY. etáal . (1998) J.áClin. Invest. 102 :1142. The ED50 for this effect is 2-5 ╡g/mL in the presence of a cross-linking antibody, Mouse Anti-polyHistidine Monoclonal Antibody (Catalog # MAB050 ) and recombinant human IFN-gamma .
endotoxin note :
<0.10 EU per 1 ╡g of the protein by the LAL method.
accessionNumbers :
Q9QYH9
applications :
Bioactivity
source long :
Mouse myeloma cell line, NS0-derived mouse LIGHT/TNFSF14 protein MHHHHHHHHHH GGGSGGGSGGGS IEGR Mouse LIGHT (Asp72-Val239) Accession # Q9QYH9 N-terminus C-terminus
source short :
NS0
USD :
432 USD
alt names :
CD258, CD258 antigen, delta transmembrane LIGHT, Herpes virus entry mediator ligand, Herpesvirus entry mediator ligand, HVEM-L, HVEMLherpesvirus entry mediator-ligand, ligand for herpesvirus entry mediator, LIGHTherpesvirus entry mediator A, LTg, TNFSF14, TR2, tumor necrosis factor (ligand) superfamily, member 14, tumor necrosis factor ligand superfamily member 14, tumor necrosis factor receptor-like 2, tumor necrosis factor superfamily member LIGHT
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 3 months, -20 to -70 ░C under sterile conditions after reconstitution.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.